| 1. |
Brain-derived neurotrophic factor and its receptor Trk-B in gall bladder carcinoma: potential biomarkers and prognostic marker |
ICMR |
Dr. Ruchika Gupta, Scientist E, Cytopathology |
Prof. Puja Sakhuja, GBPIMER; Prof. Anil Aggarwal, GBPIMER; Dr. Suresh T Hedau, ICMR-NICPR; Dr. Ratna Chopra, HRH |
March, 2021 |
March, 2024 |
Ongoing |
| 2. |
Evaluation of non-invasive adjuncts in OPMDs for early detection of oral cancer and development of risk-based OPMD management protocol in a primary healthcare setting |
ICMR |
Dr. Ruchika Gupta, Scientist E, Cytopathology |
Dr. Prashant K Singh, ICMR-NICPR; Dr. Sudhir Tanwar, ICMR-NICPR; Dr. Lucky Singh, ICMR-NIMS; Dr. Shalini Gupta, CDER, AIIMS; Dr. Apurva Ratnu, Niramay Charitable Trust, Gandhinagar |
February, 2024 |
February, 2027 |
Ongoing |
| 3. |
Identification of key genes, microRNA and transcriptional regulators in cervical cancer using Network Biology approach |
ICMR |
Dr Subhash Agarwal |
|
June, 2023 |
June, 2026 |
Ongoing |
| 4. |
To decipher and target the metabolic signatures associated with Epirubicin-resistant triple negative breast cancer |
ICMR |
Dr. Suresh Thamdeo Hedau |
Dr Mausumi Bharadwaj |
November, 2021 |
November, 2024 |
Ongoing |
| 5. |
Identification of prognostic marker for mTOR kinase inhibitor and their mechanisms of therapeutic resistance in breast cancer |
DHR |
Dr. Suresh Thamdeo Hedau |
Dr. Shalini Singh |
December, 2021 |
December, 2024 |
Ongoing |
| 6. |
Evaluating the efficacy of interferon-mediators in combination with α-fetoprotein and Des-γ -carboxy-prothrombin in diagnosing hepatocellular carcinoma |
NICPR |
Dr. Anuj Kumar |
Dr Pramod Kumar, Dr Ekta Gupta, Dr Mausumi Bharadwaj |
October, 2022 |
October,, 2024 |
Ongoing |
| 7. |
Role of genetic factors associated with smokeless tobacco cessation in northern India |
DHR(MRHRU) |
Dr. Anuj Kumar |
Dr. Sudhir Tanwar |
|
|
Sanctioned |
| 8. |
To study the 5-Flurouracil induced genes and potential of phytochemicals for drug resistance reversal in cancer cell lines : |
NICPR |
Dr Dinesh Kumar |
Dr Pramod Kumar |
April, 2023 |
March, 2026 |
Ongoing |
| 9. |
Advent of Omics Technologies in Precision Diagnostics and Targeted Therapeutics (Under HRD scheme of DHR - Support to Institutes) |
DHR |
Dr. Sandeep Kumar, Scientist B |
Dr. Showket Hussain, Scientist E |
July, 2023 |
July, 2026 |
Ongoing |
| 10. |
Decoding the epigenomic pathophysiology in Polycystic Ovary Syndrome (PCOS) and PCOS-linked gynecologic oncogenesis |
NICPR |
Dr. Sandeep Kumar, Scientist B |
Dr. Showket Hussain, Scientist E; Dr. Bindiya Gupta, Prof. UCMS and GTB Hospital |
November, 2022 |
December, 2024 |
Ongoing |
| 11. |
Validation study of indigenous HPV tests for cervical cancer screening (i-HPV) |
BIRAC |
Dr. Neerja Bhatla |
Dr. Seema Singhal ( AIIMS NEW Delhi); Dr. Shalini Singh ( Site PI); Dr. Showket Hussain |
January, 2024 |
July, 2024 |
Ongoing |
| 12. |
Development and validation of a lab-on-a-chip integrated DNA extraction and LAMP-based detection of high-risk HPV genotypes |
ICMR |
Dr. Ravi Krishnan, IIT Delhi, |
Dr. Showket Hussain, ( Site PI), Dr. Shalini Singh |
March, 2024 |
Feburary, 2027 |
Ongoing |
| 13. |
Hands on Training in HPV- DNA Diagnostics. |
DHR |
Dr. Showket Hussain |
Dr. Shalini Singh, Dr. Nazneen Arif |
March, 2024 |
March, 2029 |
Ongoing |
| 14. |
Molecular Evaluation of Anticancer and Antiviral properties of Thuja Occidentalis” |
AYUSH |
Dr.R.Suresh Kumar |
Dr. Rana Pratap singh, Dr. Arya, Dr. Binit Dwivedi |
January, 2017 |
March, 2024 |
Completed |
| 15. |
Evaluation of Histone demethylases KDM5A,5B expression and its role in oral cancers. |
NICPR |
Dr. R. Suresh Kumar |
Dr.Pravesh Mehra, Dr. Kiran Garwal, Dr. Ruchika |
April, 2021 |
March, 2025 |
ongoing |
| 16. |
Assessment of Genetic and Epigenetic Alterations in SARSCOV-2 Positive samples |
NICPR |
Dr. R. Suresh Kumar |
Dr. Shalini Singh, Dr. Nazneen |
April, 2023 |
March, 2025 |
ongoing |
| 17. |
Identification of rare variants in Pattern recognition receptors (PPRs) and their crosstalk with Interleukins and NF-kB to understand the functional Implications in Reproductive Tract Infections (RTIs) |
ICMR |
Dr.Mausumi Bharadwaj |
Dr.Shalini Singh |
December, 2021 |
November, 2024 |
ongoing |
| 18. |
Basic Molecular Biology Techniques Relevant to Cancer Research – Hands on Training |
DHR |
Dr.Mausumi Bharadwaj |
|
December, 2019 |
November, 2024 |
ongoing |
| 19. |
Setting up of “Population Based Cancer Registry at National Institute of Cancer Prevention & Research covering Gautam Budh Nagar” |
NCDIR (ICMR) |
Dr Smita Asthana |
|
August, 2017 |
March, 2024 |
Completed |
| 20. |
ICMR Capacity Strengthening Program for Disease Burden Estimation |
ICMR |
Dr Shalini Singh |
Dr Prashant K Singh, Dr Smita Asthana |
November, 2023 |
August, 2024 |
Ongoing |
| 21. |
Determinants of Human Papillomavirus vaccine acceptance among parents of girls and young women and interventions to improve vaccine uptake among girls in India (Multicentric study) |
NARI (ICMR) |
Dr. Pallavi Shidaye, Scientist C, ICMR-NARI , Dr.Ekta Gupta, (Site PI) |
Site PsI: Dr.K Rekhadevi, Sci-E, Dr.Ekta Gupta, Sci-E, ICMR-NICPR, Dr.Shrinivasa B M, Sci-C, Dr.Pournami AP, Sci-B; Dr.Santhosh Kumar, Sci-C, Dr.Tanwi Trushna, Sci-C |
January, 2024 |
December, 2025 |
Ongoing |
| 22. |
Antibody Response following One Dose of Cervavac® and One Dose of Gardasil® Vaccine in Healthy Indian Girls Aged 9-14 Years: A Non-inferiority, Multicenter, Double-blind, Randomized Controlled trial |
ICMR |
Dr. Sheela Godbole, ICMR-NARI |
Site PI: Dr. Ekta Gupta, Sci-E, ICMR-NICPR ;Dr. Suman Kanungo. Sci-F, ICMR-NICED |
|
|
Approved |
| 23. |
DLSS-Sentinel Surveillance for tuberculosis burden in India 2022-2024 -Task Force |
NIRT |
Dr Nazneen Arif |
Dr Smita Asthana Dr C.P. Yadav |
|
|
Ongoing |
| 24. |
Helicobacter pylori and Epstein-Barr virus co-infection in patients of Gastric Carcinoma |
NICPR |
Dr Nazneen Arif |
Dr Sandeep Kumar |
March, 2023 |
March, 2026 |
Ongoing |
| 25. |
Knowledge, Attitude & Practices related to Tobacco / Areca Nut use and Oral Cancer among College Students: A cross-sectional quantitative pilot study from Govt. Degree College Noida |
NICPR |
Dr. Sudhir Tanwar |
Dr. Prashant K Singh, Dr. Ruchika Gupta |
March, 2023 |
March, 2025 |
Ongoing |
| 26. |
Challenges in tobacco cessation: a mixed method, community based study from Noida, Uttar Pradesh |
NICPR |
Dr. Sudhir Tanwar |
Dr. Prashant K Singh, Dr. Ruchika Gupta |
March, 2023 |
March, 2025 |
Ongoing |
| 27. |
Understanding psychosocial determinants and other mediators in tobacco cessation and their relationship with quitting: A longitudinal, quantitative study from Karnal district in Haryana |
DHR(MRHRU) |
Dr. Sudhir Tanwar |
Dr. Prashant K Singh, Dr. Ruchika Gupta, Dr. CP Yadav |
Jan, 2024 |
December, 2026 |
Sanctioned |
| 28. |
Role of intra-tumoral microbiome in progression of Oral squamous cell carcinoma (OSCC) |
ICMR |
Dr Pramod Kumar |
Dr Shalini Singh, Dr Shalini Gupta (AIIMS, Delhi) |
January, 2024 |
January, 2027 |
Ongoing |
| 29. |
Immune response to precautionary third dose of COVISHIELD/COVAXIN among healthy adult population: an ICMR Cohort study, India |
ICMR |
Dr Pramod Kumar |
Dr Anuj Kumar |
February, 2023 |
February, 2025 |
Ongoing |
| 30. |
Genomic sequencing of HCV associated with Hepatocellular Carcinoma to identify conserved regions for vaccine candidates |
NICPR |
Dr Pramod Kumar |
Dr Anuj Kumar, Dr. Dinesh Kumar, Dr Sandhya Kabra, NCDC, Delhi, Dr Partha Rakshit, NCDC Delhi |
April, 2023 |
April, 2025 |
Ongoing |
| 31. |
In vitro effect of R-nicotine on lung and oral cancer cell proliferation |
NICPR |
Dr Pramod Kumar |
Dr Shalini Singh |
April, 2023 |
April, 2025 |
Ongoing |
| 32. |
Assessment of Immune suppressive response in tumor microenvironment in oral cancer |
NICPR |
Dr Pramod Kumar |
Dr Shalini Singh, Dr Shalini Gupta (AIIMS, Delhi) |
April, 2023 |
April, 2025 |
Ongoing |
| 33. |
Accelerating effort to END TB in India--AccEEnd TB Project - ICMR Task force Project |
NIRT (ICMR) |
Dr. CP Yadav |
Dr Nazneen Arif,Dr Smita Asthana and Dr. Kakoli |
April, 2023 |
April, 2025 |
Ongoing |
| 34. |
Development of digital malaria dashboard for easry and inromative retrieval of data from village to country level |
ICMR |
Dr. CP Yadav |
Dr. Amit Sharma, ICGEB, Dr. Srikant, VCRC and Dr. K Hari Kishan Raju, VCRC |
September, 2024 |
September, 2026 |
Ongoing |
| 35. |
WHO-FCTC knowledge hub on smokeless tobacco |
NICPR |
Dr Shalini Singh |
Dr. Prashant Kumar Singh |
|
|
Ongoing |
| 36. |
Understanding availability of Essential Diagnostics in health care system: identifying barriers and facilitators ICMR-task force Project |
ICMR |
Dr. Prashant Kumar Singh |
Dr. CP Yadav |
November, 2023 |
May, 2024 |
Ongoing |
| 37. |
Strengthening and
advancing Smokeless Tobacco Control through implementation of evidence based frameworks addressing TAPS, PHW and public use of SLT in India |
Vital Strategies, Bloomberg Initiative in Tobacco Control |
Dr. Prashant Kumar Singh |
Dr Shalini Singh |
January, 2022 |
December, 2024 |
Sanctioned |
| 38. |
MRHRU Gautam Buddha Nagar |
DHR(MRHRU) |
Dr. Prashant Kumar Singh |
Dr Sandeep Kumar |
January, 2022 |
December, 2024 |
Ongoing |
| 39. |
Trends, pattern and determinants of modifiable risk factor of cancer and other non-communicable diseases |
ICMR |
Dr. Prashant Kumar Singh |
Dr. Kakoli Borkotoky |
October, 2023 |
October, 2024 |
Ongoing |
| 40. |
Development of an Mobile App & Web based System for Screening, Risk Assessment, Management and follow-up of Tobacco Cessation : a demonstration study at NICPR, Noida |
ICMR |
Dr. Prashant Kumar Singh |
Dr Sudhir Tanwar |
Februray 2023 |
June, 2024 |
Ongoing |
| 41. |
To study the Knowledge , Attitude ,Behavior with regard to Non-Communicable diseases among the college students |
NICPR |
Dr Malasha Kumari |
Dr Smita Asthana |
March, 2023 |
December, 2024 |
Ongoing |
| 42. |
National Tobacco Testing Laboratory |
MoHFW |
Dr Shalini Singh |
Dr Muasumi Bhardwaj, Dr Anuj Kumar |
2018 |
01-03-2025 |
Ongoing |
| 43. |
MRHRU Panipat |
DHR (MRHRU) |
Dr Ruchika Gupta |
Dr CP Yadav |
2020 |
01-03-2025 |
Ongoing |
